To evaluate whether the enhancement of PLC activity was accompanied by an increased production of DAGs, we measured DAG 18:1 20:4 and DAG 18:0 20:4 concentrations in the plasma of mastocytosis patients. The gene discussed is HSPG2; the disease is mastocytosis.